{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-248475","form_type":"8-K","ticker":null,"cik":"0001689657","company_name":"PhenomeX Inc.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.065631+00:00","generated_at":"2026-06-10T06:23:55.995841+00:00","sec_items":["2.01","3.01","5.01","5.02","5.03","3.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Bruker closes $1.00/share all-cash acquisition of PhenomeX; delisting from Nasdaq","bullets":["Bruker Corp. acquired PhenomeX for $1.00/share in cash; 81.5% of outstanding shares (81.3M) tendered in the offer.","All remaining shares, options, RSUs, and restricted stock converted to cash at $1.00/share; appraisal rights available.","Former CEO Siddhartha Kadia and all prior directors/officers replaced; Mark Munch appointed President.","Company renamed Bruker Cellular Analysis, Inc.; Nasdaq delisting and SEC deregistration requested.","Amended certificate of incorporation and bylaws filed with Delaware Secretary of State effective Oct 2, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-248475","json":"https://secwatch.observer/filing/0001193125-23-248475.json","markdown":"https://secwatch.observer/filing/0001193125-23-248475.md","text":"https://secwatch.observer/filing/0001193125-23-248475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/d496355d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:23:55.995841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"151c08f40f","claim":"Peter Silvester departed as Director at PhenomeX Inc..","evidence_excerpt":"Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"23c23d1ee1","claim":"Greg Lucier departed as Director at PhenomeX Inc..","evidence_excerpt":"Greg Lucier, Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"419b2baaa3","claim":"Igor Khandros departed as Director at PhenomeX Inc..","evidence_excerpt":"Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4ad324fe60","claim":"Mark Munch was appointed as Director at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4fa41cb703","claim":"Mark Munch was appointed as other_named_officer at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became an executive officer"}],"fact_type":"executive_change"},{"claim_id":"63d1af39fa","claim":"Elizabeth Nelson departed as Director at PhenomeX Inc..","evidence_excerpt":"Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8be50c6d08","claim":"Brent Alldredge was appointed as other_named_officer at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became an executive officer"}],"fact_type":"executive_change"},{"claim_id":"8c9f5bb0ed","claim":"Jie Kong was appointed as other_named_officer at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became an executive officer"}],"fact_type":"executive_change"},{"claim_id":"9b4b923558","claim":"Siddhartha Kadia departed as Director at PhenomeX Inc..","evidence_excerpt":"Siddhartha Kadia, Greg Lucier, Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ad0d02f48f","claim":"John Chiminski departed as Director at PhenomeX Inc..","evidence_excerpt":"John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c2ab89a42a","claim":"Jessica Hopfield departed as Director at PhenomeX Inc..","evidence_excerpt":"Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c8f284173d","claim":"Michael Mortitz departed as Director at PhenomeX Inc..","evidence_excerpt":"Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e0f36fa5eb","claim":"Gerald Herman was appointed as Director at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e844cbcf5c","claim":"Brent Alldredge was appointed as Director at PhenomeX Inc..","evidence_excerpt":"each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became a director"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4305d548da2e3fdb4cc26b52d34de6a92c534d10","claim":"PhenomeX Inc.: Bylaws amended and restated in their entirety in connection with the Merger, including to reflect the name change to Bruker Cellular Analysis, Inc (effective 2023-10-02).","evidence_excerpt":"the bylaws of the Company were amended and restated in their entirety, including to reflect the Name Change","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-02"}],"fact_type":"governance_change"},{"claim_id":"b46c7595a354a2198ccbb7d8db9db40e73c422a7","claim":"PhenomeX Inc.: Certificate of incorporation amended and restated in its entirety in connection with the Merger, including changing the company name to Bruker Cellular Analysis, Inc (effective 2023-10-02).","evidence_excerpt":"the Company’s certificate of incorporation as in effect immediately prior to the Merger was amended and restated in its entirety","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-10-02"}],"fact_type":"governance_change"},{"claim_id":"d33bcd7884b3c47c5530610be6a33398b55ea78d","claim":"PhenomeX Inc. underwent a change of control involving Bruker Corporation for $1.00 per Share (closed 2023-10-02).","evidence_excerpt":"☐ Introductory Note On October 2, 2023, Bruker Corporation, a Delaware corporation (“ Parent ”), completed its previously announced acquisition of PhenomeX Inc., a Delaware corporation (the “ Company ”), pursuant to the Agreement and Plan of Merger, dated as of August 17, 2023 (the “ Merger Agreement ”), by and among the Company, Parent and Bird Mergersub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1689657/000119312523248475/0001193125-23-248475-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Bruker Corporation"},{"label":"Consideration","value":"$1.00 per Share"},{"label":"Closing","value":"2023-10-02"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}